PharmaCan Capital Corp.
TSX VENTURE : MJN

PharmaCan Capital Corp.

February 09, 2015 20:59 ET

Peace Naturals Project Inc. Announces Voluntary Recall

TORONTO, ONTARIO--(Marketwired - Feb. 9, 2015) -

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH UNITED STATES NEWSWIRE SERVICES

Peace Naturals Project Inc. ("Peace Naturals") is voluntarily recalling two lots of product shipped under the Marijuana for Medical Purposes Regulation ("MMPR").

During the course of a regular inspection at Peace Naturals, conducted under the MMPR, Health Canada inspectors determined this product was labelled with delta-tetrahydrocannabinol (THC) of 9.07% with a product specification of +/- 2% of THC. However, when retested from a third party laboratory, the product demonstrated that the content of THC may be as high as 13.7%.

While exposure to high levels of THC may be associated with increased risks of experiencing certain adverse effects, the level of THC in this product does not appear to have been high enough to trigger an increased risk to the health and safety of clients. Peace Naturals has not received reports of any adverse events or complaints associated with the use of this product, nor has Health Canada received any reports of adverse reactions. Therefore, the impact of this mislabelling represents a low risk to the health and safety of clients.

PharmaCan Capital Corp. ("PharmaCan") has a 27.3% ownership interest in Peace Naturals.

About PharmaCan Capital Corp.

PharmaCan is a company in the business of investing in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's MMPR. PharmaCan has a diversified portfolio of investments including investments in 5 of the 23 companies licensed by Heath Canada to produce medical marijuana. PharmaCan's 5 investments includes 3 of the 15 companies that are listed on Heath Canada's website as licensed to produce and sell medical marijuana as well as another 2 of the 8 companies that are listed on Health Canada's website as licensed to produce medical marijuana.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information